Sign In

Nick Plugis

Senior Principal at Flagship Pioneering

Nick Plugis is a Senior Principal at Flagship Pioneering, a prominent biotech venture creation and investment firm.2 He works on a venture-creation team to found and grow companies based on innovative biological concepts and emerging technologies.2

Professional Background

Nick joined Flagship Pioneering after completing the company's Fellows Program.3 His work at Flagship has led to the creation of several groundbreaking biotech companies, including:

  • Ring Therapeutics: Focused on revolutionizing gene therapy using a commensal virome platform1
  • Cellarity: Designing medicines targeting cell behavior rather than single molecular targets1
  • Laronde: Pioneering endless RNA (eRNA™), a new class of programmable medicines1

Previously, Nick served as the Chief Innovation Officer at Cellarity, where he created and led the company's Drug Design Studio. This initiative combined systems biology, single-cell technologies, and machine learning to develop new cell-centric chemical design capabilities.1

Education and Achievements

Nick holds a Ph.D. in Chemistry from Stanford University, where he worked with Chaitan Khosla as part of the ChEM-H innovation hub.1 His research focused on building and using chemical biology tools to investigate the molecular pathophysiology of celiac disease.1 He also completed the Stanford Graduate School of Business's Ignite Program.1

For his undergraduate studies, Nick earned a B.A. in Chemistry and Economics from Middlebury College.1

Nick's innovative work has resulted in multiple patents and publications.1 In 2021, he was recognized in Business Insider's list of 12 serial entrepreneurs building the next generation of biotech startups.1

Current Role and Impact

As a Senior Principal at Flagship Pioneering, Nick continues to play a crucial role in the creation and development of cutting-edge biotech companies. His expertise spans various fields, including synthetic biology, chemical biology, and the application of AI in drug discovery.14

Highlights

Jul 23 · linkedin

Congrats to the Abiologics team on today's unveiling!

Abiologics is surpassing the limits of nature to create Synteins™, a new class of supranatural and programmable biologics that aims to redefine what therapeutics can achieve for patients across a range of disease areas.

It was a pleasure working alongside Noubar Afeyan, Avak Kahvejian, Mike Hamill, Jaclyn Dunphy, Kala Subramanian, Alicia Kaestli, PhD, Peter Rapp, Luke Dowman, and Parashar Thapa Ph.D. in the early days of the company. I'll be cheering on the team as they strive to bring this new category of medicine to patients.

If you're interested in learning more, check out the open roles: https://lnkd.in/e-4zty9G

#biotechnology #drugdiscovery #startup #FlagshipFounded

Mar 14 · linkedin

I’m happy to share that I’m starting a new position as Senior Principal at Flagship Pioneering!

Related Questions

What are some of the companies Nick Plugis has helped found at Flagship Pioneering?
How did Nick Plugis' work at Cellarity impact the biotech industry?
What is Nick Plugis' educational background and how has it influenced his career?
Can you provide examples of Nick Plugis' contributions to drug design?
What is the significance of Nick Plugis' role as a Senior Principal at Flagship Pioneering?
Nick Plugis
Nick Plugis, photo 1
Nick Plugis, photo 2
Add to my network

Experience

Senior Principal at Flagship Pioneering, March 2023 - Present
Principal at Flagship Pioneering, October 2020 - Present, Senior Associate at Flagship Pioneering, October 2018 - October 2020, Associate at Flagship Pioneering, January 2017 - October 2018, Consultan at The MGH/HST Martinos Center for Biomedical Imaging, May 2008 - August 2009

Education

Doctor of Philosophy (Ph.D.) in Chemical Biology from Stanford University, 2011 - 2016, Stanford Ignite program from Stanford University Graduate School of Business, 2015, Bachelor of Arts (BA) in Che

Location

Cambridge, Massachusetts, United States